Cargando…
Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?
Autores principales: | Ménard, Timothé, Koneswarakantha, Björn, Rolo, Donato, Barmaz, Yves, Popko, Leszek, Bowling, Rich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048863/ https://www.ncbi.nlm.nih.gov/pubmed/31834590 http://dx.doi.org/10.1007/s40264-019-00894-3 |
Ejemplares similares
-
Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning
por: Ménard, Timothé, et al.
Publicado: (2019) -
Harnessing the Power of Quality Assurance Data: Can We Use Statistical Modeling for Quality Risk Assessment of Clinical Trials?
por: Koneswarakantha, Björn, et al.
Publicado: (2020) -
Leveraging analytics to assure quality during the Covid-19 pandemic - The COVACTA clinical study example
por: Ménard, Timothé, et al.
Publicado: (2020) -
Bayesian Modeling for the Detection of Adverse Events Underreporting in Clinical Trials
por: Barmaz, Yves, et al.
Publicado: (2021) -
Using Statistical Modeling for Enhanced and Flexible Pharmacovigilance Audit Risk Assessment and Planning
por: Zou, Min, et al.
Publicado: (2020)